Brent Vaughan

Brent is the CEO and co-founder of Cognoa, a pediatric behavioral health company that has received Breakthrough Designation from the FDA its first two prescription digital therapeutic products being developed to improve the standard of care for the diagnosis and treatment of behavioral health conditions in pediatrics - starting with autism and ADHD.

Prior to Cognoa, Brent was co-founder and COO of WellnessFX, an award winning digital health company that created a nationwide, high patient-engagement, direct-to-consumer diagnostics and telemedicine platform. Before working in digital health, Brent had leadership roles in business development, product and corporate strategy in biotech and device/diagnostics at Chiron/Novartis, Nektar and Roche.